Skip to main content

Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein: Implications for Preventing Transmission

  • Living reference work entry
  • First Online:
Encyclopedia of AIDS
  • 238 Accesses

Definition

Dendritic cells (DCs) are critical sentinels of the immune system and potent antigen-presenting cells. They patrol peripheral tissues including the blood, skin, and mucosal surfaces, poised to sense and respond to incoming microbes. Upon encountering a microbe, DCs engulf it and are triggered to migrate to the lymph nodes. Along the way they degrade the microbe and undergo a process of maturation that includes upregulation of molecules associated with antigen presentation. In the lymph node, DCs present their antigen on major histocompatibility complex (MHC) class I and II molecules to T cells and thus activate an adaptive immune response specific to the microbe. DCs can be one of the first cell types to encounter HIV. The virus has evolved to exploit the natural function of DCs, which includes avoiding degradation in order to gain access to its primary target – the CD4+T cells. DCs are therefore a key target to investigate for strategies to prevent HIV transmission. In...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Anderluh M, Jug G, Svajger U, Obermajer N. DC-SIGN antagonists, a potential new class of anti-infectives. Curr Med Chem. 2012;19(7):992–1007.

    Article  PubMed  CAS  Google Scholar 

  • Baan E, de Ronde A, Luchters S, Vyankandondera J, Lange JM, Pollakis G, Paxton WA. HIV type 1 mother-to-child transmission facilitated by distinctive glycosylation sites in the gp120 envelope glycoprotein. AIDS Res Hum Retrovir. 2012;28(7):715–24.

    Article  PubMed  CAS  Google Scholar 

  • Baan E, van der Sluis RM, Bakker ME, Bekker V, Pajkrt D, Jurriaans S, Kuijpers TW, Berkhout B, Wolthers KC, Paxton WA, Pollakis G. Human immunodeficiency virus type 1 gp120 envelope characteristics associated with disease progression differ in family members infected with genetically similar viruses. J Gen Virol. 2013;94(Pt 1):20–9.

    Article  PubMed  CAS  Google Scholar 

  • Banchereau J, Thompson-Snipes L, Zurawski S, Blanck JP, Cao Y, Clayton S, Gorvel JP, Zurawski G, Klechevsky E. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood. 2012;119(24):5742–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Banerjee K, Andjelic S, Klasse PJ, Kang Y, Sanders RW, Michael E, Durso RJ, Ketas TJ, Olson WC, Moore JP. Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo. Virology. 2009;389(1–2):108–21.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Banerjee K, Michael E, Eggink D, van Montfort T, Lasnik AB, Palmer KE, Sanders RW, Moore JP, Klasse PJ. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice. AIDS Res Hum Retrovir. 2012;28(2):206–14.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Blanchet FP, Moris A, Nikolic DS, Lehmann M, Cardinaud S, Stalder R, Garcia E, Dinkins C, Leuba F, Wu L, Schwartz O, Deretic V, Piguet V. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity. 2010;32(5):654–69.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath MJ, Nussenzweig MC, Pulendran B, Scanlan CN, Schief WR, Silvestri G, Streeck H, Walker BD, Walker LM, Ward AB, Wilson IA, Wyatt R. A blueprint for HIV vaccine discovery. Cell Host Microbe. 2012;12(4):396–407.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Chen Y, Hwang SL, Chan VS, Chung NP, Wang SR, Li Z, Ma J, Lin CW, Hsieh YJ, Chang KP, Kung SS, Wu YC, Chu CW, Tai HT, Gao GF, Zheng B, Yokoyama KK, Austyn JM, Lin CL. Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells. PLoS Pathog. 2013;9(1):e1003100.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Chung NP, Matthews K, Klasse PJ, Sanders RW, Moore JP. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells. J Immunol. 2012;189(11):5257–65.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Cohn L, Chatterjee B, Esselborn F, Smed-Sorensen A, Nakamura N, Chalouni C, Lee BC, Vandlen R, Keler T, Lauer P, Brockstedt D, Mellman I, Delamarre L. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J Exp Med. 2013;210(5):1049–63.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Cunningham AL, Harman A, Kim M, Nasr N, Lai J. Immunobiology of dendritic cells and the influence of HIV infection. Adv Exp Med Biol. 2013;762:1–44.

    Article  PubMed  CAS  Google Scholar 

  • Delamarre L, Mellman I. Harnessing dendritic cells for immunotherapy. Semin Immunol. 2011;23(1):2–11.

    Article  PubMed  CAS  Google Scholar 

  • Duthie MS, Windish HP, Fox CB, Reed SG. Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev. 2011;239(1):178–96.

    Article  PubMed  CAS  Google Scholar 

  • Fantuzzi L, Purificato C, Donato K, Belardelli F, Gessani S. Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. J Virol. 2004;78(18):9763–72.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Fehres CM, Garcia-Vallejo JJ, Unger WW, van Kooyk Y. Skin-resident antigen-presenting cells: instruction manual for vaccine development. Front Immunol. 2013;4:157.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fernando K, Hu H, Ni H, Hoxie JA, Weissman D. Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses. Blood. 2007;109(6):2538–44.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Garçon N, Leroux-Roels G, Cheng W-F. Vaccine adjuvants. Perspect Vaccinol. 2011;1(1):89–113.

    Article  Google Scholar 

  • Haim H, Si Z, Madani N, Wang L, Courter JR, Princiotto A, Kassa A, DeGrace M, McGee-Estrada K, Mefford M, Gabuzda D, Smith 3rd AB, Sodroski J. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. PLoS Pathog. 2009;5(4):e1000360.

    Article  PubMed  PubMed Central  Google Scholar 

  • Harman AN, Kraus M, Bye CR, Byth K, Turville SG, Tang O, Mercier SK, Nasr N, Stern JL, Slobedman B, Driessen C, Cunningham AL. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood. 2009;114(1):85–94.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, Botting RA, Lewin SR, Cunningham AL, Cameron PU. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol. 2013a;190(1):66–79.

    Article  PubMed  CAS  Google Scholar 

  • Harman AN, Kim M, Nasr N, Sandgren KJ, Cameron PU. Tissue dendritic cells as portals for HIV entry. Rev Med Virol. 2013b;23(5):319–33.

    Article  PubMed  CAS  Google Scholar 

  • Hu H, Fernando K, Ni H, Weissman D. HIV envelope suppresses CD4+ T cell activation independent of T regulatory cells. J Immunol. 2008;180(8):5593–600.

    Article  PubMed  CAS  Google Scholar 

  • Huskens D, Schols D. Algal lectins as potential HIV microbicide candidates. Mar Drugs. 2012;10(7):1476–97.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Lore K, Smed-Sorensen A, Vasudevan J, Mascola JR, Koup RA. Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J Exp Med. 2005;201(12):2023–33.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Martinelli E, Cicala C, Van Ryk D, Goode DJ, Macleod K, Arthos J, Fauci AS. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A. 2007;104(9):3396–401.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Matthews K, Chung NP, Klasse PJ, Moore JP, Sanders RW. Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation. J Immunol. 2012;189(12):5729–44.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Melchers M, Matthews K, de Vries RP, Eggink D, van Montfort T, Bontjer I, van de Sandt C, David K, Berkhout B, Moore JP, Sanders RW. A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells. Retrovirology. 2011;8:48.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Miller E, Bhardwaj N. Dendritic cell dysregulation during HIV-1 infection. Immunol Rev. 2013;254(1):170–89.

    Article  PubMed  Google Scholar 

  • Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, Bianco A, Steckel B, Moro M, Crosti MC, Romagnani C, Stolzel K, Torretta S, Pignataro L, Scheibenbogen C, Neddermann P, Defrancesco R, Abrignani S, Geginat J. Human CD1c+dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T cell responses. Blood. 2013;122:932–42.

    Article  PubMed  CAS  Google Scholar 

  • Parboosing R, Maguire GE, Govender P, Kruger HG. Nanotechnology and the treatment of HIV infection. Viruses. 2012;4(4):488–520.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Prasad A, Kuzontkoski PM, Shrivastava A, Zhu W, Li DY, Groopman JE. Slit2N/Robo1 inhibit HIV-gp120-induced migration and podosome formation in immature dendritic cells by sequestering LSP1 and WASp. PLoS One. 2012;7(10):e48854.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Rodriguez-Plata MT, Puigdomenech I, Izquierdo-Useros N, Puertas MC, Carrillo J, Erkizia I, Clotet B, Blanco J, Martinez-Picado J. The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein. Retrovirology. 2013;10:42.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Sagar M, Akiyama H, Etemad B, Ramirez N, Freitas I, Gummuluru S. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection. J Infect Dis. 2012;205(8):1248–57.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Sandgren KJ, Smed-Sorensen A, Forsell MN, Soldemo M, Adams WC, Liang F, Perbeck L, Koup RA, Wyatt RT, Karlsson Hedestam GB, Lore K. Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation. J Immunol. 2013;191(1):60–9.

    Article  PubMed  CAS  Google Scholar 

  • Sarkar R, Mitra D, Chakrabarti S. HIV-1 gp120 protein downregulates Nef induced IL-6 release in immature dentritic cells through interplay of DC-SIGN. PLoS One. 2013;8(3):e59073.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Schweizer A, Rusert P, Berlinger L, Ruprecht CR, Mann A, Corthesy S, Turville SG, Aravantinou M, Fischer M, Robbiani M, Amstutz P, Trkola A. CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics. PLoS Pathog. 2008;4(7):e1000109.

    Article  PubMed  PubMed Central  Google Scholar 

  • Segura E, Durand M, Amigorena S. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med. 2013;210(5):1035–47.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Shan M, Klasse PJ, Banerjee K, Dey AK, Iyer SP, Dionisio R, Charles D, Campbell-Gardener L, Olson WC, Sanders RW, Moore JP. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 2007;3(11):e169.

    Article  PubMed  PubMed Central  Google Scholar 

  • Smed-Sorensen A, Lore K. Dendritic cells at the interface of innate and adaptive immunity to HIV-1. Curr Opin HIV AIDS. 2011;6(5):405–10.

    Article  PubMed  Google Scholar 

  • Smed-Sorensen A, Lore K. Targeting dendritic cells for improved HIV-1 vaccines. Adv Exp Med Biol. 2013;762:263–88.

    Article  PubMed  Google Scholar 

  • Teixeira C, Gomes JR, Gomes P, Maurel F, Barbault F. Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug. Eur J Med Chem. 2011;46(4):979–92.

    Article  PubMed  CAS  Google Scholar 

  • Teunissen MB, Haniffa M, Collin MP. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Curr Top Microbiol Immunol. 2012;351:25–76.

    PubMed  CAS  Google Scholar 

  • Tsegaye TS, Pohlmann S. The multiple facets of HIV attachment to dendritic cell lectins. Cell Microbiol. 2010;12(11):1553–61.

    Article  PubMed  CAS  Google Scholar 

  • van Montfort T, Eggink D, Boot M, Tuen M, Hioe CE, Berkhout B, Sanders RW. HIV-1N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation. J Immunol. 2011;187(9):4676–85.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vani J, Kaveri SV, Bayry J. Myeloid dendritic cell dysfunction during primary HIV-1 infection is independent of interaction with gp120. J Infect Dis. 2012a;205(12):1893–5.

    Article  PubMed  CAS  Google Scholar 

  • Vani J, Sharma M, Shaila MS, Kaveri SV, Bayry J. Impact of gp120 on dendritic cell-derived chemokines: relevance for the efficacy of gp120-based vaccines for HIV-1. Clin Vaccine Immunol. 2012b;19(8):1335–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vicenzi E, Poli G. Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro. Tissue Antigens. 2013;81(2):61–71.

    Article  PubMed  CAS  Google Scholar 

  • Wijewardana V, Soloff AC, Liu X, Brown KN, Barratt-Boyes SM. Early myeloid dendritic cell dysregulation is predictive of disease progression in simian immunodeficiency virus infection. PLoS Pathog. 2010;6(12):e1001235.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kerrie J. Sandgren .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Sandgren, K.J., Liang, F., Smed-Sörensen, A., Loré, K. (2014). Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein: Implications for Preventing Transmission. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_133-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_133-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics